What's really in that party drug? festival study aims to find out
NCT ID NCT03203213
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at 25 people who came to medical tents at music festivals in Aquitaine, France, with signs of drug poisoning. Researchers took small blood, hair, and urine samples to identify which psychoactive substances they had taken. The goal was to track which drugs are circulating at different types of events so that prevention efforts can be more targeted.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help public health officials know which drugs are common at festivals and create better prevention messages.
- What could go wrong
- This is a small, completed observational study (25 people) that only describes what was found. It does not test a treatment or prove any cause-and-effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
25 people
The number who actually took part.
- Started
-
Jun 2017
- Finished
-
Jul 2017
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Any patient admitted to the Emergency Medical Post with neurological and / or behavioral disorders: * agitated at the time of admission to the PMA or during surveillance at the LDC * and who will say (or for whom his entourage will say that he has) consumed psychoactive substances * or who will be unable to say that they have taken a psychoactive substance and for which no other etiology is evident * and / or for which the seriousness of the case necessitates admission to the emergency or intensive care, whether or not the physician is aware of a psychoactive substance (and in the absence of an obvious etiology) * and / or if the PMA physician considers that analytical research is needed for further care * Oral Express Consent * any patient who is in possession of an identity document proving his / her majority (over 18 years). Exclusion Criteria: * Refusal of the patient to take a sample, or to participate in the study * Minors (under 18 years of age) * Pregnant women * Breastfeeding women * Patient who can not prove his / her age by the production of an identity document.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Poisoning by psychoactive substances are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Pellegrin
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.